Placement Completed
Bioxyne placement
A$3m raised
Announced 21 Mar 2025 · ASX: BXN · A$0.025 cash per share
Advisers
Bioxyne
Issuer
Not disclosed
Lead managers
- Lead manager
- Bookrunner
- Issuer
- Bioxyne
- Completed
- 27 Mar 2025
- Sector
- Biotech and pharmaceuticals
Similar deals
- NeuroScientific Biopharmaceuticals placement Apr 2025 · A$3.5m · Biotech and pharmaceuticals
- AGH placement Sep 2025 · A$2.5m · Biotech and pharmaceuticals
- AdAlta placement May 2026 · A$2.5m · Biotech and pharmaceuticals
- Biotron placement Oct 2025 · A$2.5m · Biotech and pharmaceuticals
- Recce Pharmaceuticals placement Jun 2026 · A$4m · Biotech and pharmaceuticals
Sources
- 21 Mar 2025 Bioxyne Raises A$3 million in Capital Raise ASX
- 27 Mar 2025 Application for quotation of securities - BXN ASX